PDCD1 and atherosclerosis: These results, together with those from previous studies that explored the function of IFN-γ [26, 27] and PD-1/PD-L1 inhibitors [28], suggest that the inhibition of IFN-γ and PD-1/PD-L1 might reduce atherosclerosis.